secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2022-03-14T23:59:59+00:00
Accession:  0000950170-22-003590
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spruce Biosciences enters ATM offering for up to $21M in common stock
---------------------------------------------------------------------

- Agreement with Jefferies LLC to sell up to $21M of common stock via at-the-market offerings.
- Shares sold at market prices on Nasdaq; Jefferies receives 3% commission on gross proceeds.
- Company not obligated to sell; offering may be suspended or terminated upon notice.
- Prospectus supplement filed under existing shelf registration effective Feb 11, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000095017022003590/0000950170-22-003590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000095017022003590/sprb-20220314.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-003590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer